nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A meta-analysis of microRNA expression profiling studies in heart failure
|
Gholaminejad, Alieh |
|
|
26 |
4 |
p. 997-1021 |
artikel |
2 |
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
|
Zhang, Liyan |
|
|
26 |
4 |
p. 897-917 |
artikel |
3 |
Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization
|
Hattori, Yoshiyuki |
|
|
26 |
4 |
p. 947-952 |
artikel |
4 |
Cardiac 1H MR spectroscopy: development of the past five decades and future perspectives
|
Gupta, Ashish |
|
|
26 |
4 |
p. 839-859 |
artikel |
5 |
Cardiotoxicity in HER2-positive breast cancer patients
|
Gonciar, Diana |
|
|
26 |
4 |
p. 919-935 |
artikel |
6 |
Device-based treatment options for heart failure with preserved ejection fraction
|
Miyagi, Chihiro |
|
|
26 |
4 |
p. 749-762 |
artikel |
7 |
Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies
|
Ito, Takahide |
|
|
26 |
4 |
p. 813-828 |
artikel |
8 |
Etiologies and predictors of readmission among obese and morbidly obese patients admitted with heart failure
|
Ram, Pradhum |
|
|
26 |
4 |
p. 829-838 |
artikel |
9 |
High-density lipoprotein-mediated cardioprotection in heart failure
|
Jackson, Ampadu O. |
|
|
26 |
4 |
p. 767-780 |
artikel |
10 |
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
|
Silva-Cardoso, José |
|
|
26 |
4 |
p. 891-896 |
artikel |
11 |
Obstructive sleep apnea and cardiac mechanics: how strain could help us?
|
Tadic, Marijana |
|
|
26 |
4 |
p. 937-945 |
artikel |
12 |
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
|
Fabiani, Iacopo |
|
|
26 |
4 |
p. 881-890 |
artikel |
13 |
Peripartum cardiomyopathy
|
Jha, Nivedita |
|
|
26 |
4 |
p. 781-797 |
artikel |
14 |
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
|
Bistola, Vasiliki |
|
|
26 |
4 |
p. 861-879 |
artikel |
15 |
Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic
|
Palazzuoli, Alberto |
|
|
26 |
4 |
p. 973-979 |
artikel |
16 |
Sodium-glucose co-transporter 2 inhibitors and heart failure—the present and the future
|
Nana, Melanie |
|
|
26 |
4 |
p. 953-960 |
artikel |
17 |
The role of mechanotransduction in heart failure pathobiology—a concise review
|
Krueger, Wolfgang |
|
|
26 |
4 |
p. 981-995 |
artikel |
18 |
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19
|
García-Escobar, Artemio |
|
|
26 |
4 |
p. 961-971 |
artikel |
19 |
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review
|
Rabkin, Simon W. |
|
|
26 |
4 |
p. 799-812 |
artikel |
20 |
Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients
|
Rorris, Filippos-Paschalis |
|
|
26 |
4 |
p. 763-765 |
artikel |